Pharmacodynamics of amoxicillin against Mannheimia haemolytica and Pasteurella multocida and pharmacokinetic/pharmacodynamic (PK/PD) correlation in sheep

Research in Veterinary Science

Volumn 89, Issue 3, 2010, Pages 418-425

  Delis, G A ^a   Koutsoviti Papadopoulou, M ^a   Siarkou, V I ^a   Kounenis, G ^a   Batzias, G C ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Amoxicillin; Pharmacokinetic pharmacodynamic correlation; Sheep; Tissue cage

Indexed keywords

AMOXICILLIN; AMOXYKEL; SILICONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG TISSUE LEVEL; MANNHEIMIA HAEMOLYTICA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PASTEURELLA MULTOCIDA; PASTEURELLA MULTOCIDA INFECTION; PHARMACODYNAMICS; PNEUMONIC PASTEURELLOSIS; PREDICTION; SHEEP;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MANNHEIMIA HAEMOLYTICA; MICROBIAL SENSITIVITY TESTS; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; PASTEURELLACEAE INFECTIONS; SHEEP; SHEEP DISEASES;

MANNHEIMIA HAEMOLYTICA; OVIS ARIES; PASTEURELLA MULTOCIDA;

EID: 78049238996     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2010.03.018     Document Type: Article

References (50)

1. Aliabadi F.S., Lees P. Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf. Research in Veterinary Science 2003, 74:247-259.
2. Aliabadi F.S., Ali B.H., Landoni M.F., Lees P. Pharmacokinetics and PK-PD modelling of danofloxacin in camel serum and tissue cage fluids. The Veterinary Journal 2003, 165:104-118.
3. Aliabadi F.S., Landoni M.F., Lees P. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy 2003, 47:626-635.
4. Baggot J.D. The Physiological Basis of Veterinary Clinical Pharmacology 2001, Blackwell Science Ltd., Osney Mead, Oxford, UK.
5. Bishop Y. The Veterinary Formulary 2001, Pharmaceutical Press, London, UK. fifth ed.
6. Boswell F.J., Ashby J.P., Andrews J.M., Wise R. Effect of protein binding on the in vivo activity and pharmacodynamics of faropenem. Journal of Antimicrobial Chemotherapy 2002, 50:525-532.
7. Burgess D.S., Hall R.G. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae. Diagnostic Microbiology and Infectious Disease 2004, 49:41-46.
8. Cárceles C.M., Escudero E., Baggot J.D. Comparative pharmacokinetics of amoxicillin/clavulanic acid combination after intravenous administration to sheep and goats. Journal of Veterinary Pharmacology and Therapeutics 1995, 18:132-136.
9. Cassirer E.F., Rudolph K.M., Fowler P., Coggins V.L., Hunter D.L., Miller M.W. Evaluation of ewe vaccination as a tool for increasing bighorn lamb survival following pasteurellosis epizootics. Journal of Wildlife Diseases 2001, 37:49-57.
10. Clarke C.R. Tissue-chamber modeling systems-applications in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 1989, 12:349-368.
11. Craig W.A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 1998, 26:1-12.
12. Craigmill A.L., Pass M.A., Weltzlich S. Comparative pharmacokinetics of amoxicillin administered intravenously to sheep and goats. Journal of Veterinary Pharmacology and Therapeutics 1992, 15:72-77.
13. Davidson R.J., Zhanel G.G., Phillips R., Hoban D.J. Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 1991, 35:1261-1263.
14. Delis G., Batzias G., Kounenis G., Koutsoviti-Papadopoulou M. Application and validation of a LC/fluorescence method for the determination of amoxicillin in sheep serum and tissue cage fluid. Journal of Pharmaceutical and Biomedical Analysis 2009, 49:375-380.
15. Delis, G.A., Koutsoviti-Papadopoulou, M., Theodosiadou, E., Kounenis, G., Batzias, G.A., 2009b. Peripheral distribution of amoxicillin in sheep and influence of local inflammation. The Veterinary Journal. doi:10.1016/j.tvjl.2009.06.005 [Epub ahead of print].
16. DeRyke C.A., Nicolau D.P. Is all free time above the minimum inhibitory concentration the same: implications for β-lactam in vivo modelling. International Journal of Antimicrobial Agents 2007, 29:341-343.
17. Diallo I.S., Frost A.J. Survival of avian strains of Pasteurella multocida in chicken serum. Veterinary Microbiology 2000, 72:153-161.
18. Elsheikh H.A., Taha A.A., Khalafalla A.E., Osman I.A.M., Wasfi I.A. Pharmacokinetics of amoxicillin trihydrate in desert sheep and nubian goats. Veterinary Research Communications 1999, 23:507-514.
19. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), 2000. Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. EUCAST Definitive Document E.Def 1.2.
20. Fernandez C., Modamio P., Mestorino N., Errecalde J.O., Mariño E.L. Pharmacokinetics of sodium and trihydrate amoxicillin in sheep after intravenous and intramuscular administration. Journal of Veterinary Pharmacology and Therapeutics 2007, 30:263-266.
21. Ferran A., Dupouy V., Toutain P.-L., Bousquet-Mélou A. Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin. Antimicrobial Agents and Chemotherapy 2007, 51:4163-4166.
22. Firsov A.A., Lubenko I.Y., Portnoy Y.A., Zinner S.H., Vostrov S.N. Relationships of the area under the curve/MIC ratio to different integral endpoints of the antimicrobial effect: gemifloxacin pharmacodynamics in an in vitro dynamic model. Antimicrobial Agents and Chemotherapy 2001, 45:917-931.
23. Frimodt-Møller N. How predictive is PK/PD for antibacterial agents?. International Journal of Antimicrobial Agents 2002, 19:333-339.
24. Gabrielsson J., Weiner D. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications 2000, Swedish Pharmaceutical Press, Stockholm, Sweden. third ed.
25. Gardiner W.P., Gettinby G. Experimental Design Techniques in Statistical Practice: A Practical Software-based Approach 1998, Horwood Publishing Limited, Westergate, UK.
26. Haritova A.M., Rusenova N.V., Parvanov P.R., Lashev L.D., Fink-Gremmels J. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys. Antimicrobial Agents and Chemotherapy 2006, 50:3779-3785.
27. Jacobs M.R. Combating resistance. application of the emerging science of pharmacokinetics and pharmacodynamics. International Journal of Antimicrobial Agents 2007, 30(Suppl. 2):122-126.
28. Katsube T., Yamano Y., Yano Y. Pharmacokinetic-pharmacodynamic modeling and simulation for in vivo bactericidal effect in murine infection model. Journal of Pharmaceutical Sciences 2008, 97:1606-1614.
29. Lam F.C., Hung C.T., Perrier D.G. Estimation of variance for harmonic mean half-lives. Journal of Pharmaceutical Sciences 1985, 74:229-231.
30. Lindecrona R.H., Friis C., Jensen N.E. The pharmacodynamic effect of amoxycillin and danofloxacin against Actinobacillus pleuropneumoniae in an in-vitro pharmacodynamic model. Research in Veterinary Science 1999, 67:93-97.
31. MacGowan A.P., Noel A.R., Rogers C.A., Bowker K.E. Antibacterial effects of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae strains for which MICs are high, in an in vitro pharmacokinetic model. Antimicrobial Agents and Chemotherapy 2004, 48:2599-2603.
32. Madaras-Kelly K.J., Demasters T.A. In vitro characterization of fluoroquinolone concentration/MIC antimicrobial activity and resistance while simulating clinical pharmacokinetics of levofloxacin, oxfloxacin, or ciprofloxacin against Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease 2000, 37:253-260.
33. McKellar Q.A. Antimicrobial resistance: a veterinary perspective. Antimicrobials are important for animal welfare but need to be used prudently. British Medical Journal 1998, 317:610-611.
34. McKellar Q.A., Sanchez Bruni S.F., Jones D.G. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 2004, 27:503-514.
35. McNabb J.J., Bui K.Q. β-Lactam pharmacodynamics. Antimicrobial Pharmacodynamics in Theory and Clinical Practice 2002, 99-123. Marcel Dekker AG, Basel, Switzerland. C.H. Nightingale, T. Murakawa, P.G. Ambrose (Eds.).
36. Moine P., Mazoit J.-X., Bédos J.-P., Valée É., Azoulay-Dupuis E. Correlation between in vitro and in vivo activity of amoxicillin against Streptococcus pneumoniae in a murine pneumonia model. The Journal of Pharmacology and Experimental Therapeutics 1997, 280:310-315.
37. National Committee of Clinical Laboratory Standards - NCCLS, 2003. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard-6th ed. doc. M7-A6, vol. 23 (No. 2). National Committee of Clinical Laboratory Standards, Villanova, PA, USA.
38. Nightingale C.H., Murakawa T. Microbiology and pharmacokinetics. Antimicrobial Pharmacodynamics in Theory and Clinical Practice 2002, 23-39. Marcel Dekker AG, Basel, Switzerland. C.H. Nightingale, T. Murakawa, P.G. Ambrose (Eds.).
39. Noreddin A.M., Roberts D., Nichol K., Wierzbowski A., Hoban D.J., Zhanel G.G. Pharmacodynamic modeling of clarithromycin against macrolide-resistant [PCR-positive mef(A) or erm(B)] Streptococcus pneumoniae simulating clinically achievable serum and epithelial lining fluid free-drug concentrations. Antimicrobial Agents and Chemotherapy 2002, 46:4029-4034.
40. Odenholt-Tornqvist I., Löwdin E., Cars O. Pharmacodynamic effects of subinhibitory concentrations of β-lactam antibiotics in vitro. Antimicrobial Agents and Chemotherapy 1991, 35:1834-1839.
41. Pellet T., Gicquel-Bruneau M., Sanders P., Laurentie M. Comparison of faecal and optimal growth conditions on in vitro pharmacodynamic activity of marbofloxacin against Escherichia coli. Research in Veterinary Science 2006, 80:324-335.
42. Prescott J.F. Beta-lactam antibiotics: penam penicillins. Antimicrobial Therapy in Veterinary Medicine 2006, 121-1137. Blackwell Publishing Professional, Ames, IA, USA. fourth ed. S. Giguère, J.F. Prescott, J.D. Baggot, R.D. Walker, P.M. Dowling (Eds.).
43. Regoes R.R., Wiuff C., Zappala R.M., Garner K.N., Baquero F., Levin B.R. Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens. Antimicrobial Agents and Chemotherapy 2004, 48:3670-3676.
44. Roberts J.A., Paratz J., Paratz E., Krueger W.A., Lipman J. Continuous infusion of β-lactam antibiotics in severe infections: a review of its role. International Journal of Antimicrobial Agents 2007, 30:11-18.
45. Rolinson G.N. Forty years of β-lactam research. Journal of Antimicrobial Chemotherapy 1998, 41:589-603.
46. Schwarz S., Kehrenberg C., Walsh T.R. Use of antimicrobial agents in veterinary medicine and food animal production. International Journal of Antimicrobial Agents 2001, 17:431-437.
47. Stratton C.W. Molecular mechanisms of action for antimicrobial agents: general principles and mechanisms for selected classes of antibiotics. Antibiotics in Laboratory Medicine 2005, Lippincott Williams and Wilkins, Philadelphia, PA, USA. fifth ed. V. Lorian (Ed.).
48. Sutherland R., Croydon E.A.P., Rolinson G.N. Amoxycillin: a new semi-synthetic penicillin. British Medical Journal 1972, 3:13-16.
49. Toutain P.L., del Castillo J.R.E., Bousquet-Mélou A. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science 2002, 73:105-114.
50. Washburn K., Johnson R., Clarke C.R., Anderson K., Lucas M., Bryson W., Robinson J., Dame K., Hubbard V., Callahan K., Robb E. Penetration of ceftiofur into sterile vs. Mannheimia haemolytica-infected tissue chambers in beef calves after subcutaneous administration of ceftiofur crystalline free acid sterile suspension in the ear pinna. Journal of Veterinary Pharmacology and Therapeutics 2005, 28:247-251.